Veterinarians in the US now have a new, innovative option for flea and tick control as Elanco Animal Health Incorporated (NYSE: ELAN) introduces Credelio Cat, the first oral flea and tick product for cats.
Credelio Cat starts killing fleas on cats within 6 hours. The small, chewable product maintains fast-acting, long-lasting flea efficacy in cats 8 weeks and older. Credelio Cat also protects against black-legged ticks in cats from 6 months of age all month long. Black-legged ticks are the most common type of tick in cats in the United States1
“Even domestic cats are threatened by fleas and ticks,” said Dr. Tony Rumschlag, Senior Director, Technical Consulting. “It’s great to have a unique flea and tick option for cat owners who prefer oral delivery or want to try something other than a topical product. Credelio Cat, which uses the active ingredient Lotilaner, has been shown to be safe and effective when used Used to kill fleas in cats 8 weeks or older weighing 2 pounds or more as directed on the label, so veterinarians can be comfortable prescribing it to their patients. “
While oral administration has been a challenge in the past, Credelio Cat was specifically designed for cats to ensure the smell and taste of vanilla and yeast is appealing.2 The product was tested in a US field study by 99.5% of the Successfully administered to cat owners. 3
Credelio Cat, approved by the US Food and Drug Administration (FDA), complements Elanco’s growing animal health portfolio, which includes solutions in parasiticides, pain management, vaccines, internal medicine, oncology and dermatology.
For more information on the Credelio Cat and Elanco cat health portfolio, please visit: https://www.elanco.us/products-services/cats/credelio-cat
Indications
Credelio CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations for one month in cats and kittens aged 8 weeks and over and weighing 2 pounds or more.
The story goes on
Credelio CAT is also indicated for the treatment and control of black leg tick infestations for one month in cats and kittens 6 months and older and weighing 2 pounds or more.
important safety notice
Lotilaner is a member of the isoxazoline class. This class has been associated with neurological side effects such as tremors, incoordination, and seizures. Neurological side effects have been reported in cats receiving isoxazoline-class drugs, even in cats with no history of neurological disorders. Use with caution in cats with a history of neurological disorders. The safety of Credelio CAT has not been proven in breeding, pregnant and lactating cats. The effectiveness of Credelio CAT against black-legged ticks in kittens under 6 months of age has not been evaluated. The most commonly reported side effects are weight loss, rapid breathing, and vomiting. Refer to the Credelio CAT product label or ask your veterinarian for complete safety information.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health, dedicated to innovating and delivering products and services for the prevention and treatment of diseases in farm animals and pets and of value to farmers, pet owners, veterinarians, stakeholders and others society creates a whole. With nearly 70 years of animal health experience, we aim to help our customers improve the health of the animals they care for while making a meaningful impact on our local and global communities. At Elanco, we are guided by our vision of enriching life through food and companions, and our Elanco Healthy Purpose ™ sustainability / ESG commitments – all to promote the health of animals, people and the planet. Learn more at www.elanco.com.
1Little SE, Barrett AW, Nagamori Y. et al. Ticks from Cats in the United States: Patterns of Infestation and Infection with Pathogens. Vet Parasitol. 2018; 257: 15.
2Toutain CE, Seewald W., Jung M. Pharmacokinetics of Lotilaner after single oral or intravenous administration in cats. Parasite vector. 2018; 11: 412.
3Chappell K., Paarlberg T., Seewald W. et al. A randomized, controlled field study evaluating the efficacy and safety of lotilan flavored chewable tablets (Credelio ™ CAT) in eliminating fleas in cats owned by customers in the United States. Parasite vector. 2021; 14: 127.
Credelio, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2021 Elanco or affiliates. PM-US-21-1141
View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005099/de/
contacts
Investor Contact: Tiffany Kanaga +1.302.897.0668 Tiffany.Kanaga@elancoah.com
Media contact: Sarah Morehouse +1.317.914.7568 Sarah.Morehouse@network.elancoah.com